---
schema_version: "secwatch.filing_event.v1"
accession: "0001736730-25-000043"
form_type: "8-K"
ticker: "CAMP"
cik: "0001736730"
company_name: "Camp4 Therapeutics Corp"
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:40:54.474261+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# CAMP4 Therapeutics annual meeting elects four Class I directors, ratifies EY as auditor

## Summary
- James Boylan elected with 15,802,709 votes for, 900,961 against, 6,002 abstain.
- Amir Nashat, Andrew Schwab, and Douglas Williams each elected with >16 million votes for.
- Ratification of Ernst & Young as auditor for FY2025: 17,900,199 for, 2,644 against, 6,002 abstain.
- All proposals passed; meeting held June 11, 2025 as scheduled.

## SEC filing metadata
- accession: 0001736730-25-000043
- form_type: 8-K
- ticker: CAMP
- cik: 0001736730
- company_name: Camp4 Therapeutics Corp
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/0001736730-25-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736730/000173673025000043/camp-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001736730-25-000043
- JSON: https://secwatch.observer/filing/0001736730-25-000043.json
- Plain text: https://secwatch.observer/filing/0001736730-25-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.